What you'll learn

  • Apply the latest advances in the neurobiology of psychiatric disorders and understand the potential role of pharmacogenomic testing in the selection of specific psychiatric medications.
  • Assess and compare current mechanisms and latest treatment of psychotic disorders, schizophrenia and bipolar illness.
  • Evaluate treatment options for treatment resistant bipolar and unipolar depression including psychotherapies.
  • To assess the neurobiological mechanism and evidence-based treatment of depressive and anxiety spectrum disorders including PTSD.
  • See the course registration page for additional learning objectives.

Course description

 This is an accredited, in-person course offered by Beth Israel Deaconess Medical Center.

Select the Take Course button to view additional information on the course registration page.

*Register before Februaru 14 for the discounted price. 

Contact ceprograms@hms.harvard.edu with questions.

Enroll now.
Learn More